1 Introduction to Research & Analysis Reports
1.1 Erlotinib HCl Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Erlotinib HCl Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Erlotinib HCl Overall Market Size
2.1 Global Erlotinib HCl Market Size: 2022 VS 2029
2.2 Global Erlotinib HCl Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Erlotinib HCl Sales: 2018-2029
3 Company Landscape
3.1 Top Erlotinib HCl Players in Global Market
3.2 Top Global Erlotinib HCl Companies Ranked by Revenue
3.3 Global Erlotinib HCl Revenue by Companies
3.4 Global Erlotinib HCl Sales by Companies
3.5 Global Erlotinib HCl Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Erlotinib HCl Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Erlotinib HCl Product Type
3.8 Tier 1, Tier 2 and Tier 3 Erlotinib HCl Players in Global Market
3.8.1 List of Global Tier 1 Erlotinib HCl Companies
3.8.2 List of Global Tier 2 and Tier 3 Erlotinib HCl Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Erlotinib HCl Market Size Markets, 2022 & 2029
4.1.2 Purity ≥ 99%
4.1.3 Purity ≥ 99.5%
4.2 By Type – Global Erlotinib HCl Revenue & Forecasts
4.2.1 By Type – Global Erlotinib HCl Revenue, 2018-2023
4.2.2 By Type – Global Erlotinib HCl Revenue, 2024-2029
4.2.3 By Type – Global Erlotinib HCl Revenue Market Share, 2018-2029
4.3 By Type – Global Erlotinib HCl Sales & Forecasts
4.3.1 By Type – Global Erlotinib HCl Sales, 2018-2023
4.3.2 By Type – Global Erlotinib HCl Sales, 2024-2029
4.3.3 By Type – Global Erlotinib HCl Sales Market Share, 2018-2029
4.4 By Type – Global Erlotinib HCl Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Erlotinib HCl Market Size, 2022 & 2029
5.1.2 Tablet
5.1.3 Other
5.2 By Application – Global Erlotinib HCl Revenue & Forecasts
5.2.1 By Application – Global Erlotinib HCl Revenue, 2018-2023
5.2.2 By Application – Global Erlotinib HCl Revenue, 2024-2029
5.2.3 By Application – Global Erlotinib HCl Revenue Market Share, 2018-2029
5.3 By Application – Global Erlotinib HCl Sales & Forecasts
5.3.1 By Application – Global Erlotinib HCl Sales, 2018-2023
5.3.2 By Application – Global Erlotinib HCl Sales, 2024-2029
5.3.3 By Application – Global Erlotinib HCl Sales Market Share, 2018-2029
5.4 By Application – Global Erlotinib HCl Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Erlotinib HCl Market Size, 2022 & 2029
6.2 By Region – Global Erlotinib HCl Revenue & Forecasts
6.2.1 By Region – Global Erlotinib HCl Revenue, 2018-2023
6.2.2 By Region – Global Erlotinib HCl Revenue, 2024-2029
6.2.3 By Region – Global Erlotinib HCl Revenue Market Share, 2018-2029
6.3 By Region – Global Erlotinib HCl Sales & Forecasts
6.3.1 By Region – Global Erlotinib HCl Sales, 2018-2023
6.3.2 By Region – Global Erlotinib HCl Sales, 2024-2029
6.3.3 By Region – Global Erlotinib HCl Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Erlotinib HCl Revenue, 2018-2029
6.4.2 By Country – North America Erlotinib HCl Sales, 2018-2029
6.4.3 US Erlotinib HCl Market Size, 2018-2029
6.4.4 Canada Erlotinib HCl Market Size, 2018-2029
6.4.5 Mexico Erlotinib HCl Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Erlotinib HCl Revenue, 2018-2029
6.5.2 By Country – Europe Erlotinib HCl Sales, 2018-2029
6.5.3 Germany Erlotinib HCl Market Size, 2018-2029
6.5.4 France Erlotinib HCl Market Size, 2018-2029
6.5.5 U.K. Erlotinib HCl Market Size, 2018-2029
6.5.6 Italy Erlotinib HCl Market Size, 2018-2029
6.5.7 Russia Erlotinib HCl Market Size, 2018-2029
6.5.8 Nordic Countries Erlotinib HCl Market Size, 2018-2029
6.5.9 Benelux Erlotinib HCl Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Erlotinib HCl Revenue, 2018-2029
6.6.2 By Region – Asia Erlotinib HCl Sales, 2018-2029
6.6.3 China Erlotinib HCl Market Size, 2018-2029
6.6.4 Japan Erlotinib HCl Market Size, 2018-2029
6.6.5 South Korea Erlotinib HCl Market Size, 2018-2029
6.6.6 Southeast Asia Erlotinib HCl Market Size, 2018-2029
6.6.7 India Erlotinib HCl Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Erlotinib HCl Revenue, 2018-2029
6.7.2 By Country – South America Erlotinib HCl Sales, 2018-2029
6.7.3 Brazil Erlotinib HCl Market Size, 2018-2029
6.7.4 Argentina Erlotinib HCl Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Erlotinib HCl Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Erlotinib HCl Sales, 2018-2029
6.8.3 Turkey Erlotinib HCl Market Size, 2018-2029
6.8.4 Israel Erlotinib HCl Market Size, 2018-2029
6.8.5 Saudi Arabia Erlotinib HCl Market Size, 2018-2029
6.8.6 UAE Erlotinib HCl Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Rundu Pharma
7.1.1 Rundu Pharma Company Summary
7.1.2 Rundu Pharma Business Overview
7.1.3 Rundu Pharma Erlotinib HCl Major Product Offerings
7.1.4 Rundu Pharma Erlotinib HCl Sales and Revenue in Global (2018-2023)
7.1.5 Rundu Pharma Key News & Latest Developments
7.2 Fuan Pharmaceutical
7.2.1 Fuan Pharmaceutical Company Summary
7.2.2 Fuan Pharmaceutical Business Overview
7.2.3 Fuan Pharmaceutical Erlotinib HCl Major Product Offerings
7.2.4 Fuan Pharmaceutical Erlotinib HCl Sales and Revenue in Global (2018-2023)
7.2.5 Fuan Pharmaceutical Key News & Latest Developments
7.3 CHICO Pharmaceutical
7.3.1 CHICO Pharmaceutical Company Summary
7.3.2 CHICO Pharmaceutical Business Overview
7.3.3 CHICO Pharmaceutical Erlotinib HCl Major Product Offerings
7.3.4 CHICO Pharmaceutical Erlotinib HCl Sales and Revenue in Global (2018-2023)
7.3.5 CHICO Pharmaceutical Key News & Latest Developments
7.4 Huadong Medicine
7.4.1 Huadong Medicine Company Summary
7.4.2 Huadong Medicine Business Overview
7.4.3 Huadong Medicine Erlotinib HCl Major Product Offerings
7.4.4 Huadong Medicine Erlotinib HCl Sales and Revenue in Global (2018-2023)
7.4.5 Huadong Medicine Key News & Latest Developments
7.5 Suzhou Lixin Pharmaceutical
7.5.1 Suzhou Lixin Pharmaceutical Company Summary
7.5.2 Suzhou Lixin Pharmaceutical Business Overview
7.5.3 Suzhou Lixin Pharmaceutical Erlotinib HCl Major Product Offerings
7.5.4 Suzhou Lixin Pharmaceutical Erlotinib HCl Sales and Revenue in Global (2018-2023)
7.5.5 Suzhou Lixin Pharmaceutical Key News & Latest Developments
7.6 Bestcomm Pharmaceutical
7.6.1 Bestcomm Pharmaceutical Company Summary
7.6.2 Bestcomm Pharmaceutical Business Overview
7.6.3 Bestcomm Pharmaceutical Erlotinib HCl Major Product Offerings
7.6.4 Bestcomm Pharmaceutical Erlotinib HCl Sales and Revenue in Global (2018-2023)
7.6.5 Bestcomm Pharmaceutical Key News & Latest Developments
7.7 Teva Pharmaceutical
7.7.1 Teva Pharmaceutical Company Summary
7.7.2 Teva Pharmaceutical Business Overview
7.7.3 Teva Pharmaceutical Erlotinib HCl Major Product Offerings
7.7.4 Teva Pharmaceutical Erlotinib HCl Sales and Revenue in Global (2018-2023)
7.7.5 Teva Pharmaceutical Key News & Latest Developments
7.8 JEIL PHARMACEUTICAL
7.8.1 JEIL PHARMACEUTICAL Company Summary
7.8.2 JEIL PHARMACEUTICAL Business Overview
7.8.3 JEIL PHARMACEUTICAL Erlotinib HCl Major Product Offerings
7.8.4 JEIL PHARMACEUTICAL Erlotinib HCl Sales and Revenue in Global (2018-2023)
7.8.5 JEIL PHARMACEUTICAL Key News & Latest Developments
7.9 NEWEDGE OVERSEAS
7.9.1 NEWEDGE OVERSEAS Company Summary
7.9.2 NEWEDGE OVERSEAS Business Overview
7.9.3 NEWEDGE OVERSEAS Erlotinib HCl Major Product Offerings
7.9.4 NEWEDGE OVERSEAS Erlotinib HCl Sales and Revenue in Global (2018-2023)
7.9.5 NEWEDGE OVERSEAS Key News & Latest Developments
7.10 Mac-Chem
7.10.1 Mac-Chem Company Summary
7.10.2 Mac-Chem Business Overview
7.10.3 Mac-Chem Erlotinib HCl Major Product Offerings
7.10.4 Mac-Chem Erlotinib HCl Sales and Revenue in Global (2018-2023)
7.10.5 Mac-Chem Key News & Latest Developments
8 Global Erlotinib HCl Production Capacity, Analysis
8.1 Global Erlotinib HCl Production Capacity, 2018-2029
8.2 Erlotinib HCl Production Capacity of Key Manufacturers in Global Market
8.3 Global Erlotinib HCl Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Erlotinib HCl Supply Chain Analysis
10.1 Erlotinib HCl Industry Value Chain
10.2 Erlotinib HCl Upstream Market
10.3 Erlotinib HCl Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Erlotinib HCl Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界のエルロチニブ塩酸塩市場予測2023-2029：純度≧99%、純度≧99.5% |
| 【英語タイトル】Erlotinib HCl Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU0687 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：76 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：化学＆材料 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界のエルロチニブ塩酸塩市場規模と予測を収録しています。・世界のエルロチニブ塩酸塩市場：売上、2018年-2023年、2024年-2029年 ・世界のエルロチニブ塩酸塩市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のエルロチニブ塩酸塩市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「純度≧99%」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 エルロチニブ塩酸塩のグローバル主要企業は、Rundu Pharma、 Fuan Pharmaceutical、 CHICO Pharmaceutical、 Huadong Medicine、 Suzhou Lixin Pharmaceutical、 Bestcomm Pharmaceutical、 Teva Pharmaceutical、 JEIL PHARMACEUTICAL、 NEWEDGE OVERSEAS、 Mac-Chemなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、エルロチニブ塩酸塩のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のエルロチニブ塩酸塩市場：タイプ別、2018年-2023年、2024年-2029年 世界のエルロチニブ塩酸塩市場：タイプ別市場シェア、2022年 ・純度≧99%、純度≧99.5% 世界のエルロチニブ塩酸塩市場：用途別、2018年-2023年、2024年-2029年 世界のエルロチニブ塩酸塩市場：用途別市場シェア、2022年 ・錠剤、その他 世界のエルロチニブ塩酸塩市場：地域・国別、2018年-2023年、2024年-2029年 世界のエルロチニブ塩酸塩市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるエルロチニブ塩酸塩のグローバル売上、2018年-2023年 ・主要企業におけるエルロチニブ塩酸塩のグローバル売上シェア、2022年 ・主要企業におけるエルロチニブ塩酸塩のグローバル販売量、2018年-2023年 ・主要企業におけるエルロチニブ塩酸塩のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Rundu Pharma、 Fuan Pharmaceutical、 CHICO Pharmaceutical、 Huadong Medicine、 Suzhou Lixin Pharmaceutical、 Bestcomm Pharmaceutical、 Teva Pharmaceutical、 JEIL PHARMACEUTICAL、 NEWEDGE OVERSEAS、 Mac-Chem ************************************************************* ・調査・分析レポートの概要 エルロチニブ塩酸塩市場の定義 市場セグメント 世界のエルロチニブ塩酸塩市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のエルロチニブ塩酸塩市場規模 世界のエルロチニブ塩酸塩市場規模：2022年 VS 2029年 世界のエルロチニブ塩酸塩市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのエルロチニブ塩酸塩の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のエルロチニブ塩酸塩製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：純度≧99%、純度≧99.5% エルロチニブ塩酸塩のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：錠剤、その他 エルロチニブ塩酸塩の用途別グローバル売上・予測 ・地域別市場分析 地域別エルロチニブ塩酸塩市場規模 2022年と2029年 地域別エルロチニブ塩酸塩売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Rundu Pharma、 Fuan Pharmaceutical、 CHICO Pharmaceutical、 Huadong Medicine、 Suzhou Lixin Pharmaceutical、 Bestcomm Pharmaceutical、 Teva Pharmaceutical、 JEIL PHARMACEUTICAL、 NEWEDGE OVERSEAS、 Mac-Chem ... |
This report aims to provide a comprehensive presentation of the global market for Erlotinib HCl, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erlotinib HCl. This report contains market size and forecasts of Erlotinib HCl in global, including the following market information:
Global Erlotinib HCl Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Erlotinib HCl Market Sales, 2018-2023, 2024-2029, (Tons)
Global top five Erlotinib HCl companies in 2022 (%)
The global Erlotinib HCl market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Purity ≥ 99% Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Erlotinib HCl include Rundu Pharma, Fuan Pharmaceutical, CHICO Pharmaceutical, Huadong Medicine, Suzhou Lixin Pharmaceutical, Bestcomm Pharmaceutical, Teva Pharmaceutical, JEIL PHARMACEUTICAL and NEWEDGE OVERSEAS, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Erlotinib HCl manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Erlotinib HCl Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Erlotinib HCl Market Segment Percentages, by Type, 2022 (%)
Purity ≥ 99%
Purity ≥ 99.5%
Global Erlotinib HCl Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Erlotinib HCl Market Segment Percentages, by Application, 2022 (%)
Tablet
Other
Global Erlotinib HCl Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Erlotinib HCl Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Erlotinib HCl revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Erlotinib HCl revenues share in global market, 2022 (%)
Key companies Erlotinib HCl sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Erlotinib HCl sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Rundu Pharma
Fuan Pharmaceutical
CHICO Pharmaceutical
Huadong Medicine
Suzhou Lixin Pharmaceutical
Bestcomm Pharmaceutical
Teva Pharmaceutical
JEIL PHARMACEUTICAL
NEWEDGE OVERSEAS
Mac-Chem
Outline of Major Chapters:
Chapter 1: Introduces the definition of Erlotinib HCl, market overview.
Chapter 2: Global Erlotinib HCl market size in revenue and volume.
Chapter 3: Detailed analysis of Erlotinib HCl manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Erlotinib HCl in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Erlotinib HCl capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界のエルロチニブ塩酸塩市場予測2023-2029：純度≧99%、純度≧99.5%] (コード：MMG23JU0687)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のエルロチニブ塩酸塩市場予測2023-2029：純度≧99%、純度≧99.5%]についてメールでお問い合わせ |
